1. Home
  2. ACIU vs BIOX Comparison

ACIU vs BIOX Comparison

Compare ACIU & BIOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACIU
  • BIOX
  • Stock Information
  • Founded
  • ACIU 2003
  • BIOX 2001
  • Country
  • ACIU Switzerland
  • BIOX Argentina
  • Employees
  • ACIU N/A
  • BIOX N/A
  • Industry
  • ACIU Biotechnology: Pharmaceutical Preparations
  • BIOX Agricultural Chemicals
  • Sector
  • ACIU Health Care
  • BIOX Industrials
  • Exchange
  • ACIU Nasdaq
  • BIOX Nasdaq
  • Market Cap
  • ACIU 247.4M
  • BIOX 275.1M
  • IPO Year
  • ACIU 2016
  • BIOX N/A
  • Fundamental
  • Price
  • ACIU $1.77
  • BIOX $4.24
  • Analyst Decision
  • ACIU Strong Buy
  • BIOX Strong Buy
  • Analyst Count
  • ACIU 2
  • BIOX 4
  • Target Price
  • ACIU $12.00
  • BIOX $9.88
  • AVG Volume (30 Days)
  • ACIU 185.3K
  • BIOX 257.9K
  • Earning Date
  • ACIU 05-12-2025
  • BIOX 05-12-2025
  • Dividend Yield
  • ACIU N/A
  • BIOX N/A
  • EPS Growth
  • ACIU N/A
  • BIOX N/A
  • EPS
  • ACIU N/A
  • BIOX 0.02
  • Revenue
  • ACIU $30,136,397.00
  • BIOX $407,732,105.00
  • Revenue This Year
  • ACIU N/A
  • BIOX N/A
  • Revenue Next Year
  • ACIU $680.74
  • BIOX $7.55
  • P/E Ratio
  • ACIU N/A
  • BIOX $190.15
  • Revenue Growth
  • ACIU 84.51
  • BIOX N/A
  • 52 Week Low
  • ACIU $1.77
  • BIOX $3.69
  • 52 Week High
  • ACIU $4.98
  • BIOX $13.18
  • Technical
  • Relative Strength Index (RSI)
  • ACIU 25.49
  • BIOX 42.00
  • Support Level
  • ACIU $1.77
  • BIOX $4.31
  • Resistance Level
  • ACIU $2.05
  • BIOX $5.09
  • Average True Range (ATR)
  • ACIU 0.12
  • BIOX 0.37
  • MACD
  • ACIU -0.02
  • BIOX 0.03
  • Stochastic Oscillator
  • ACIU 0.00
  • BIOX 20.56

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

Share on Social Networks: